Article Information
PubMed
Published By
History
- Received March 13, 2009
- Revision received June 18, 2009
- Accepted June 24, 2009
- First published September 23, 2009.
- Version of record published September 23, 2009.
Copyright & Usage
Copyright © 2009 Society for Neuroscience 0270-6474/09/2911828-13$15.00/0
Author Information
- 1Department of Neurology and Neurosurgery, Montreal Neurological Institute, McGill University, Montreal, Quebec H3A 2B4, Canada, and
- 2Department of Pharmacology, School of Medicine, Kyungpook National University, Daegu 700-422, South Korea
- Correspondence should be addressed to Dr. Barbara E. Jones, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada. barbara.jones{at}mcgill.ca
Author contributions
Disclosures
- Received March 13, 2009.
- Revision received June 18, 2009.
- Accepted June 24, 2009.
-
This work was supported by the Canadian Institutes of Health Research (CIHR MOP-13458) and National Institutes of Health (NIH R01 MH-60119-01A). We thank for their assistance Lynda Mainville in immunohistochemistry, Frederic Brischoux in neuroanatomy, Soufiane Boucetta in experimentation, and Chris Cordova in data analysis. We also thank Robert H. Edwards and Robert T. Fremeau (Departments of Neurology and Physiology, University of California San Francisco School of Medicine, San Francisco, CA) for kindly supplying the antibodies for VGluT2.
- Correspondence should be addressed to Dr. Barbara E. Jones, Montreal Neurological Institute, McGill University, 3801 University Street, Montreal, QC H3A 2B4, Canada. barbara.jones{at}mcgill.ca
